.RESEARCH STUDY FEATURE.06 August 2024.
A huge randomized measured trial along with cisgender ladies highlights the challenges of fidelity to an everyday dental preexposure prophylaxis routine as well as illustrates that twice-yearly injection of lenacapavir can easily sustain reliable HIV deterrence levels over 6 months.